$CYN
Cyngn Inc. Stock $cyn

$cyn Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000121390023020719 Filed on March 17, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$872.8K	$262.0K	$262.0K
YoY Change
Cost Of Revenue	$616.7K	$186.8K	$186.8K
YoY Change
Gross Profit	$256.1K	$75.18K	$75.18K
YoY Change
Gross Profit Margin	29.34%	28.69%	28.69%
Selling, General & Admin	$3.071M	$2.947M	$9.995M
YoY Change	43.67%	89.11%	126.65%
% of Gross Profit	1199.08%	3920.44%	13294.73%
Research & Development	$3.030M	$2.819M	$9.481M
YoY Change	80.24%	35.96%	89.99%
% of Gross Profit	1183.13%	3749.14%	12612.01%
Depreciation & Amortization	$228.0K	$193.4K	$604.9K
YoY Change	230.24%	1020.28%	604.49%
% of Gross Profit	89.04%	257.2%	804.6%
Operating Expenses	$3.030M	$5.766M	$9.481M
YoY Change	-20.65%	58.77%	0.86%
Operating Profit	-$5.845M	-$5.691M	-$19.40M
YoY Change	53.06%		106.39%
Interest Expense	$46.90K	$41.41K	$44.10K
YoY Change	-12442.11%	9102.22%	-560.33%
% of Operating Profit
Other Income/Expense, Net	$216.1K	$103.3K	$164.2K
YoY Change		-460.54%	2190.35%
Pretax Income	-$5.629M	-$5.546M	-$19.24M
YoY Change	47.39%	169.63%	146.64%
Income Tax	$0.00		$850.00
% Of Pretax Income
Net Earnings	-$5.629M	-$5.546M	-$19.24M
YoY Change	47.39%	169.63%	146.64%
Net Earnings / Revenue	-644.91%	-2116.85%	-7342.18%
Basic Earnings Per Share	-$0.17		-$0.62
Diluted Earnings Per Share	-$0.17	-$0.16	-$0.62
COMMON SHARES
Basic Shares Outstanding	33.72M shares	33.68M shares	31.23M shares
Diluted Shares Outstanding	33.70M shares		31.23M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.96M	$22.60M	$22.60M
YoY Change	-7.5%	2.98%	2.98%
Cash & Equivalents	$7.968M	$10.54M	$10.54M
Short-Term Investments	$8.989M	$12.06M	$12.06M
Other Short-Term Assets	$1.385M	$1.176M	$1.176M
YoY Change	117.82%	104.44%	104.44%
Inventory		$66.78K
Prepaid Expenses		$706.5K
Receivables
Other Receivables
Total Short-Term Assets	$18.34M	$23.78M	$23.78M
YoY Change	-3.3%	5.57%	5.57%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.250M	$884.0K	$1.255M
YoY Change	15.15%	760.03%	1121.12%
Goodwill
YoY Change
Intangibles	$509.3K	$473.1K
YoY Change		1430.15%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.993M	$1.728M	$1.728M
YoY Change	78.58%	1192.61%	1192.64%
TOTAL ASSETS
Total Short-Term Assets	$18.34M	$23.78M	$23.78M
Total Long-Term Assets	$1.993M	$1.728M	$1.728M
Total Assets	$20.33M	$25.51M	$25.51M
YoY Change	1.25%	12.58%	12.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$443.6K	$155.9K	$155.9K
YoY Change	368.48%	38.9%	38.9%
Accrued Expenses	$94.99K	$283.1K	$1.232M
YoY Change	-86.81%	243.26%	334.44%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$913.9K	$1.387M	$1.387M
YoY Change	11.91%	240.55%	240.55%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$913.9K	$1.387M	$1.387M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$913.9K	$1.387M	$1.387M
YoY Change	-12.57%	240.55%	240.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$141.4M	-$135.7M
YoY Change		16.51%
Common Stock	$337.00	$337.00
YoY Change		27.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$9.000M	$12.10M
YoY Change
Treasury Stock Shares
Shareholders Equity	$19.42M	$24.12M	$24.12M
YoY Change
Total Liabilities & Shareholders Equity	$20.33M	$25.51M	$25.51M
YoY Change	1.25%	12.58%	12.58%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$5.629M	-$5.546M	-$19.24M
YoY Change	47.39%	169.63%	146.64%
Depreciation, Depletion And Amortization	$228.0K	$193.4K	$604.9K
YoY Change	230.24%	1020.28%	604.49%
Cash From Operating Activities	-$5.377M	-$4.700M	-$16.30M
YoY Change	58.15%	58.91%	88.6%
INVESTING ACTIVITIES
Capital Expenditures	$447.7K	$278.8K	$918.3K
YoY Change	-297.32%	-733.86%	-1576.4%
Acquisitions
YoY Change
Other Investing Activities	$3.200M	$9.884M	-$12.43M
YoY Change		-197780.6%	-29564.19%
Cash From Investing Activities	$2.752M	$9.605M	-$13.35M
YoY Change	-1312.95%	-19706.57%	66579.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$18.12M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$6.844K	0.000	$18.24M
YoY Change	-92.3%	-100.0%	-24.64%
NET CHANGE
Cash From Operating Activities	-$5.377M	-4.700M	-$16.30M
Cash From Investing Activities	$2.752M	9.605M	-$13.35M
Cash From Financing Activities	$6.844K	0.000	$18.24M
Net Change In Cash	-$2.618M	4.905M	-$11.41M
YoY Change	-26.0%	-75.83%	-173.42%
FREE CASH FLOW
Cash From Operating Activities	-$5.377M	-$4.700M	-$16.30M
Capital Expenditures	$447.7K	$278.8K	$918.3K
Free Cash Flow	-$5.825M	-$4.979M	-$17.22M
YoY Change	83.57%	70.88%	100.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-40932
CY2022	dei	Entity Registrant Name EntityRegistrantName	CYNGN INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-2007094
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	1015 O’Brien Dr
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Menlo Park
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94025
CY2022	dei	City Area Code CityAreaCode	(650)
CY2022	dei	Local Phone Number LocalPhoneNumber	924-5905
CY2022	dei	Security12b Title Security12bTitle	Common Stock, Par Value $0.00001
CY2022	dei	Trading Symbol TradingSymbol	CYN
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	11277345	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	33719592	shares
CY2022	dei	Auditor Name AuditorName	Marcum LLP
CY2022	dei	Auditor Location AuditorLocation	San Jose, California
CY2022	dei	Auditor Firm AuditorFirmId	688
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10536273	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21945981	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	50000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	50000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	12064337	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1126137	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	525304	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	23776747	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	22521285	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	884000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	102787	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	371189	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	473076	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	30917	usd
CY2022Q4	us-gaap	Assets Assets	25505012	usd
CY2021Q4	us-gaap	Assets Assets	22654989	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	155943	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	112271	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	854920	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	295156	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	376622	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1387485	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	407427	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1387485	usd
CY2021Q4	us-gaap	Liabilities Liabilities	407427	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33684864	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33684864	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26487680	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26487680	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	337	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	265	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	159847229	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	138740827	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-135730039	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-116493530	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	24117527	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	22247562	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25505012	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22654989	usd
CY2022	us-gaap	Revenues Revenues	262000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	186823	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9481329	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4990407	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9994575	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4409651	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	19662727	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	9400058	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-19400727	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-9400058	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	44100	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9580	usd
CY2022	us-gaap	Other Income OtherIncome	120118	usd
CY2021	us-gaap	Other Income OtherIncome	7173	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1602936	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	164218	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1600529	usd
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense		usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-19236509	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-7799529	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31233071	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5861730	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	5597734	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	14220	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	23125493	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	170397	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1139247	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-7799529	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	22247562	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	114169	usd
CY2022	cyngn	Issuance Of Common Stock And Prefunded Warrants In Connection With The Private Placement Offe IssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithThePrivatePlacementOffe	11989509	usd
CY2022	cyngn	Issuance Of Common Stock Upon Exercise Of Prefunded Warrants IssuanceOfCommonStockUponExerciseOfPrefundedWarrants	2662	usd
CY2022	cyngn	Issuance Of Common Warrants In Connection With The Private Placement IssuanceOfCommonWarrantsInConnectionWithThePrivatePlacement	6132436	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2867698	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-19236509	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	24117527	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-19236509	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-7799529	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	604871	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	85855	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2867698	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1139247	usd
CY2021	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	31355	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	90216	usd
CY2021	cyngn	Gain On Forgiveness Of Paycheck Protection Program Loans GainOnForgivenessOfPaycheckProtectionProgramLoans	1602936	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1425126	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	476452	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	43672	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	39255	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	936387	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	3496	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16299223	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8642419	usd
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	918318	usd
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	62204	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	456822	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	27000000	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	15025879	usd
CY2021	cyngn	Proceed From Sale Of Other Productive Assets ProceedFromSaleOfOtherProductiveAssets	-42189	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13349261	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-20015	usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	23295890	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	18121945	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2662	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	892115	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	114169	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	14220	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18238776	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24202225	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-11409708	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	15539791	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21995981	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6456190	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10586273	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21995981	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	10131	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	16719	usd
CY2021Q4	cyngn	Purchase An Additional Shares Of Common Stock PurchaseAnAdditionalSharesOfCommonStock	525000	shares
CY2022Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	110000000	shares
CY2022Q4	cyngn	Common Stock Shares CommonStockShares	100000000	shares
CY2022Q4	cyngn	Preferred Stock Share Issued PreferredStockShareIssued	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Redemption Price Per Share PreferredStockRedemptionPricePerShare	0.00001
CY2022	us-gaap	Conversion Of Stock Description ConversionOfStockDescription	Pursuant to the Purchase Agreement, the Company sold (i) 3,790,322 shares of its Common Stock together with Common Warrants to purchase up to 3,790,322 shares of Common Stock, and (ii) 2,661,291 Pre-Funded Warrants with each Pre-Funded Warrant exercisable for one share of Common Stock, together with Common Warrants to purchase up to 2,661,291 shares of Common Stock.
CY2022	cyngn	Offering Price OfferingPrice	3.09
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.98
CY2022Q4	us-gaap	Long Term Debt Term LongTermDebtTerm	P5Y
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	19200000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	7800000	usd
CY2022Q4	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	135700000	usd
CY2021Q4	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	116500000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	16300000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	8600000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the balance sheet date, as well as reported amounts of revenue and expenses during the reporting period. The Company’s significant estimates and judgments include but are not limited to warrants and share-based compensation. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p>
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash, which is placed with high-credit-quality financial institutions and at times exceeds federally insured limits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cash maintained with domestic financial institutions generally exceed the Federal Deposit Insurance Corporation insurable limit. To date, the Company has not experienced any losses on its deposits of cash. Cyngn invests in U.S. Treasury securities and carries these at amortized cost and recognizes gains and losses when realized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2022Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	10500000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	21900000	usd
CY2022Q4	us-gaap	Restricted Cash And Investments RestrictedCashAndInvestments	50000	usd
CY2021Q4	us-gaap	Restricted Cash And Investments RestrictedCashAndInvestments	50000	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	10536273	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	21945981	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	50000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	50000	usd
CY2022Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	10586273	usd
CY2021Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	21995981	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	283118	usd
CY2022	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P15Y
CY2022Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	100000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P15Y
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	82478	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	566608	usd
CY2022	cyngn	Revenue Percentage RevenuePercentage	0.954	pure
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	201000	usd
CY2022Q4	us-gaap	Amount Of Deferred Costs Related To Long Term Contracts AmountOfDeferredCostsRelatedToLongTermContracts	100000	usd
CY2022	cyngn	Performance Obligations Amount PerformanceObligationsAmount	1400000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	12100000	usd
CY2022Q4	cyngn	Automobiles Automobiles	397816	usd
CY2021Q4	cyngn	Automobiles Automobiles	279617	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	176402	usd
CY2021Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	133102	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	380457	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	76048	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	93120	usd
CY2022Q4	us-gaap	Public Utilities Property Plant And Equipment Construction Work In Progress PublicUtilitiesPropertyPlantAndEquipmentConstructionWorkInProgress	359289	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1407084	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	488767	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	523084	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	385980	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	884000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	102787	usd
CY2022	us-gaap	Depreciation Depreciation	137105	usd
CY2021	us-gaap	Depreciation Depreciation	82389	usd
CY2022Q4	cyngn	Credit Card Payable CreditCardPayable	5194	usd
CY2021Q4	cyngn	Credit Card Payable CreditCardPayable	11678	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	854920	usd
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	295156	usd
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	67958	usd
CY2022	us-gaap	Related Party Tax Expense Due To Affiliates Deferred RelatedPartyTaxExpenseDueToAffiliatesDeferred	67958	usd
CY2022	cyngn	Rent Expense RentExpense	47000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	382326	usd
CY2022Q4	us-gaap	Receivable With Imputed Interest Net Amount ReceivableWithImputedInterestNetAmount	5704	usd
CY2022Q4	us-gaap	Present Value Of Future Minimum Lease Payments Sale Leaseback Transactions PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions	376622	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y8M1D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.044	pure
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	517296	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	236476	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	453103	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	usd
CY2022Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	21982491	shares
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	508821	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-35745	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	473076	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	52000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-21083	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	30917	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	14662	usd
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	3466	usd
CY2020Q2	us-gaap	Other Borrowings OtherBorrowings	695078	usd
CY2020Q2	us-gaap	Investment Interest Rate InvestmentInterestRate	0.0098	pure
CY2020Q2	cyngn	Maturity Date MaturityDate	P24M
CY2021Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	892115	usd
CY2021Q1	cyngn	Maturity Date MaturityDate	P5Y
CY2021Q1	us-gaap	Debt Instrument Basis Spread On Variable Rate1 DebtInstrumentBasisSpreadOnVariableRate1	0.0098	pure
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33684864	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33684864	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26487680	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26487680	shares
CY2020Q4	us-gaap	Preferred Units Authorized PreferredUnitsAuthorized	21982491	shares
CY2020Q4	cyngn	Preferred Stock Par Or State Value Per Share PreferredStockParOrStateValuePerShare	0.00001
CY2022Q4	cyngn	Series A Shares Issued And Outstanding SeriesASharesIssuedAndOutstanding	21982491	shares
CY2022	us-gaap	Preferred Stock Amount Of Preferred Dividends In Arrears PreferredStockAmountOfPreferredDividendsInArrears	112265042	usd
CY2022Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	112265042	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6591613	shares
CY2022	cyngn	Fair Value FairValue	6302833	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19236509	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7799529	usd
CY2022	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	31233071	shares
CY2021	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	5861730	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
CY2022	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	14931146	usd
CY2021	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	8769694	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3583173	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	525000	shares
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	140000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	140000	usd
CY2022	cyngn	Earnings Per Share Total EarningsPerShareTotal	18654319	shares
CY2021	cyngn	Earnings Per Share Total EarningsPerShareTotal	9434694	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.52
CY2022	cyngn	Weighted Average Per Share Grantdate Fair Value Of Options Granted WeightedAveragePerShareGrantdateFairValueOfOptionsGranted	0.59
CY2022	cyngn	Fair Value Is Recognized FairValueIsRecognized	The resulting fair value is recognized on a straight-line basis over the period during which an employee is required to provide service in exchange for the award. The Company has elected to recognize forfeitures as they occur. Stock options generally vest over four years and have a contractual term of ten years.
CY2022	cyngn	Common Stock Shares Issurance CommonStockSharesIssurance	3600000	shares
CY2021	cyngn	Common Stock Shares Issurance CommonStockSharesIssurance	10500000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8769694	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.2
CY2020Q4	cyngn	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P7Y1M24D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	15746916	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	6842500	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.2
CY2021	cyngn	Stocks Issued During Period Shares Stock Options Exercised StocksIssuedDuringPeriodSharesStockOptionsExercised	717041	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.16
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1012175	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	180043	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.77
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14715110	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.23
CY2022Q4	cyngn	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P7Y10M2D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2571013	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	14715110	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.23
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y10M2D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	2571013	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	6266135	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.73
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y7M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	2555579	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	244566	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.52
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	28530	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	5.52
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	216036	shares
CY2021	cyngn	Weighted Average Per Share Grantdate Fair Value Of Options Granted WeightedAveragePerShareGrantdateFairValueOfOptionsGranted	2.78
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.2
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.78
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y10D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y1M24D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0377	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0095	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.4872	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.51	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	cyngn	Stockbased Compensation Expense From Stock Options StockbasedCompensationExpenseFromStockOptions	2900000	usd
CY2021	cyngn	Stockbased Compensation Expense From Stock Options StockbasedCompensationExpenseFromStockOptions	1100000	usd
CY2022	us-gaap	Present Value Of Future Insurance Profits Weighted Average Amortization Period PresentValueOfFutureInsuranceProfitsWeightedAverageAmortizationPeriod	P3Y6M
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	850	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	800	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0	pure
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	850	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	800	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	850	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	800	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	850	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	800	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.21	pure
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	70982	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	40173	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	39200954	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4039453	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1635786	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-415015	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-543984	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	22081	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	-308449	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Other IncomeTaxReconciliationTaxCreditsOther	673881	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Other IncomeTaxReconciliationTaxCreditsOther	897331	usd
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	1779	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	204047	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	150330	usd
CY2022	cyngn	Deferred Tax Assets Trueup DeferredTaxAssetsTrueup	386624	usd
CY2021	cyngn	Deferred Tax Assets Trueup DeferredTaxAssetsTrueup	26751	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4516446	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3207490	usd
CY2022	cyngn	Federal Statutory Income Tax Rate Total FederalStatutoryIncomeTaxRateTotal	850	usd
CY2021	cyngn	Federal Statutory Income Tax Rate Total FederalStatutoryIncomeTaxRateTotal	800	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	30186203	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	28231596	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	4867437	usd
CY2021Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	4193556	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	1303262	usd
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	1772704	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	61295	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	89979	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	654860	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	243970	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	87233	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts	1969682	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	34571977	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	39088423	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	34571977	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	112531	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	85975	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-26536	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	112531	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4516446	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	3207490	usd
CY2022	us-gaap	Subsidiary Or Equity Method Investee Cumulative Percentage Ownership After All Transactions SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions	0.50	pure
CY2022	cyngn	Taxable Income Percentage TaxableIncomePercentage	0.50	pure
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1797238	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1412668	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	288806	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	199218	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	185352	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2086044	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1797238	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	2086044	usd
CY2022	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	usd
CY2021	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions		usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions		usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions		usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense		usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments		usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset		usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021	us-gaap	Revenues Revenues		usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2022	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets		usd
CY2022	cyngn	Gain On Forgiveness Of Paycheck Protection Program Loans GainOnForgivenessOfPaycheckProtectionProgramLoans		usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
CY2022	cyngn	Proceed From Sale Of Other Productive Assets ProceedFromSaleOfOtherProductiveAssets		usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2022	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	114700	usd
CY2021Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross		usd
CY2021Q4	us-gaap	Public Utilities Property Plant And Equipment Construction Work In Progress PublicUtilitiesPropertyPlantAndEquipmentConstructionWorkInProgress		usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31233071	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5861730	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.33
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant		shares
CY2022	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock		shares
CY2021Q4	cyngn	Aggregate Intrinsic Value Granted AggregateIntrinsicValueGranted		usd
CY2021Q4	cyngn	Aggregate Intrinsic Value Cancelledforfeited AggregateIntrinsicValueCancelledforfeited		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001874097

Files In Submission

Name	View Source	Status
cyngn-20221231_cal.xml	Edgar Link	unprocessable
cyngn-20221231_pre.xml	Edgar Link	unprocessable
0001213900-23-020719-index-headers.html	Edgar Link	pending
0001213900-23-020719-index.html	Edgar Link	pending
0001213900-23-020719.txt	Edgar Link	pending
0001213900-23-020719-xbrl.zip	Edgar Link	pending
cyngn-20221231.xsd	Edgar Link	pending
cyngn-20221231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10k2022ex21-1_cyngninc.htm	Edgar Link	pending
f10k2022ex23-1_cyngninc.htm	Edgar Link	pending
f10k2022ex31-1_cyngninc.htm	Edgar Link	pending
f10k2022ex31-2_cyngninc.htm	Edgar Link	pending
f10k2022ex32-1_cyngninc.htm	Edgar Link	pending
f10k2022_cyngninc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img_001.jpg	Edgar Link	pending
img_002.jpg	Edgar Link	pending
img_003.jpg	Edgar Link	pending
img_004.jpg	Edgar Link	pending
img_005.jpg	Edgar Link	pending
img_006.jpg	Edgar Link	pending
img_007.jpg	Edgar Link	pending
img_008.jpg	Edgar Link	pending
img_009.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
cyngn-20221231_def.xml	Edgar Link	unprocessable
f10k2022_cyngninc_htm.xml	Edgar Link	completed
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CYN
Cyngn Inc. Stock $cyn

2023 Q1 Form 10-K Financial Statement

#000121390023020719 Filed on March 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CYN Cyngn Inc. Stock $cyn

2023 Q1 Form 10-K Financial Statement

#000121390023020719 Filed on March 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CYN
Cyngn Inc. Stock $cyn